We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1q92

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1q92.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1q92.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1q92| PDB=1q92 | SCENE= }}
{{STRUCTURE_1q92| PDB=1q92 | SCENE= }}
-
'''Crystal structure of human mitochondrial deoxyribonucleotidase in complex with the inhibitor PMcP-U'''
+
===Crystal structure of human mitochondrial deoxyribonucleotidase in complex with the inhibitor PMcP-U===
-
==Overview==
+
<!--
-
Monophosphate nucleotidases are enzymes that dephosphorylate nucleotides to their corresponding nucleosides. They play potentially important roles in controlling the activation of nucleotide-based drugs targeted against viral infections or cancer cells. The human mitochondrial deoxyribonucleotidase (dNT-2) dephosphorylates thymidine and deoxyuridine monophosphates. We describe the high resolution structures of the dNT-2 enzyme in complex with two potent nucleoside phosphonate inhibitors, (S)-1-[2'-deoxy-3',5'-O-(1-phosphono) benzylidene-beta-d-threo-pentofuranosyl]thymine (DPB-T) at 1.6-A resolution and (+/-)-1-trans-(2-phosphonomethoxycyclopentyl)uracil (PMcP-U) at 1.4-A resolution. The mixed competitive inhibitor DPB-T and the competitive inhibitor PMcP-U both bind in the active site of dNT-2 but in distinctly different binding modes, explaining their different kinetics of inhibition. The pyrimidine part of the inhibitors binds with very similar hydrogen bond interactions to the protein but with their phosphonate moieties in different binding sites compared with each other and to the previously determined position of phosphate bound to dNT-2. Together, these phosphate/phosphonate binding sites describe what might constitute a functionally relevant phosphate entrance tunnel to the active site. The structures of the inhibitors in complex with dNT-2, being the first such complexes of any nucleotidase, might provide important information for the design of more specific inhibitors to control the activation of nucleotide-based drugs.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15044615}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15044615 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15044615}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Rinaldo-Matthis, A.]]
[[Category: Rinaldo-Matthis, A.]]
[[Category: Alpha-beta rossman fold]]
[[Category: Alpha-beta rossman fold]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 06:01:13 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 15:02:27 2008''

Revision as of 12:02, 27 July 2008

Image:1q92.png

Template:STRUCTURE 1q92

Crystal structure of human mitochondrial deoxyribonucleotidase in complex with the inhibitor PMcP-U

Template:ABSTRACT PUBMED 15044615

About this Structure

1Q92 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal structures of the mitochondrial deoxyribonucleotidase in complex with two specific inhibitors., Rinaldo-Matthis A, Rampazzo C, Balzarini J, Reichard P, Bianchi V, Nordlund P, Mol Pharmacol. 2004 Apr;65(4):860-7. PMID:15044615

Page seeded by OCA on Sun Jul 27 15:02:27 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1q92"
Personal tools